tbuckley/cabot-search huggingface dataset:
Bad Air.
Journal: JAMA (2003)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
SECONDARY GLAUCOMA.
Authors: S. D. RISLEY
Journal: JAMA (1898)

It is probable that under the title of this paper might be quite correctly classified all classes of inflammatory glaucoma whether acute or chronic. There would then remain a comparatively small, illy defined group of cases of a non-inflammatory type to be designated as simple or primary. Increasing clinical experience has surely taught that the increased tension of the eyeball, the insensitive and steamy cornea, the impairment of peripheral and central vision is a group of symptoms frequently occurring as a resultant of widely diverse pathologic processes. For example, we find this important and interesting symptom-group as a sequel to hemorrhagic retinitis, or to chronic but steadily advancing disease of the uvea in gouty subjects. We meet it again in cases of dislocated lens, or following large rents in the lens capsule caused either by discission operations or by accidental traumatisms, which cause a rapid swelling of its substance and
A Potent Src/Abl Kinase Inhibitor (Ap23464) Potently Inhibits the Growth of Myeloid Leukemic Cells Characterized by Flt3-Itd Expression, GM-CSF Dependency, or G-CSF Responsiveness Via an Abl-Independent Mechanism.
Authors: Jukka Kanerva, Ogonna Nwawka, Kevin Hwang, William C. Shakespeare, Chester A. Metcalf, Tomi K. Sawyer, Camille L. Bedrosian, Seth J. Corey
Journal: Blood (2004)
Cholesterol in Human Tissues
Journal: JAMA (1963)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
A QUEER SURGICAL OVERSIGHT.
Journal: JAMA (1905)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Ito cell heterogeneity: Desmin-negative Ito cells in normal rat liver
Authors: G Ballardini
Journal: Hepatology (1994)

The presence of desmin is used to identify Ito cells in rat liver and to evaluate the purity of separated and cultured Ito cells. Heterogeneity of the normal Ito cell population has been suggested; this could include variations in the content of cytoskeletal components. For these reasons we decided to reevaluate the use of desmin staining as a phenotypical marker of Ito cells in normal rat liver. Our approach was to combine desmin staining with identification of vitamin A (autofluorescence), lipid droplets (Sudan III), vimentin, laminin and tenascin, using cryostat sections: Immunofluorescence, double-immunofluorescence or immunoperoxidase techniques were used. All the techniques described corroborate the existence of desmin-negative Ito cells, mainly located in pericentral areas. In fact, lobular desmin-positive cells showed uneven distribution because they were more frequent in periportal than in pericentral areas. On the contrary, Ito cells identified on the basis of morphological criteria or positivity for laminin were evenly distributed. Double immunofluorescence confirmed this observation, showing nearly complete codistribution of laminin and desmin in periportal areas. Outside this area, positivity for desmin was observed only in about 50 of lamininpositive cells. Our observations suggest that desmin cannot be viewed as a phenotypical marker but rather is a differentiation marker of Ito cells, possibly indicating a specific functional state. (Hepatology 1994;19:440–446).
Abstract 4338: Enhancer mapping in triple negative breast cancer as a tool for biomarker and oncogene discovery
Authors: Ryan Raisner, Russell Bainer, Karen Gascoigne
Journal: Cancer Research (2019)

Abstract Triple Negative Breast Cancer (TNBC) represents a heterogeneous disease with no common drivers or effective targeted therapies. Here we use ChIP-Seq combined with RNA-Seq to map the gene-regulatory landscape of TNBC in cell lines and primary tumors. Using this approach we identify novel actionable subtypes of the disease based on enhancer activity. We also identify novel tumor-specific enhancers and associated enhancer-driven oncogenes, and confirm enhancer status as a predictive biomarker of gene dependency. Citation Format: Ryan Raisner, Russell Bainer, Karen Gascoigne. Enhancer mapping in triple negative breast cancer as a tool for biomarker and oncogene discovery [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2019; 2019 Mar 29-Apr 3; Atlanta, GA. Philadelphia (PA): AACR; Cancer Res 2019;79(13 Suppl):Abstract nr 4338.
Autonomic Epilepsy
Authors: ANDRIES I. ROODENBURG
Journal: Annals of Internal Medicine (1978)

Letters and Corrections1 July 1978Autonomic EpilepsyANDRIES I. ROODENBURG, M.D., F.A.C.P.ANDRIES I. ROODENBURG, M.D., F.A.C.P.Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-89-1-149_1 SectionsAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail ExcerptTo the editor: While reading the article "Autonomic Epilepsy: Clonidine Blockade of Paroxysmal Catecholamine Release and Flushing," by Metz, Halter, Porte, and Robertson (Ann Intern Med 88:189-193, 1978), I remembered the case of a 74-year-old man whom I saw in February 1971.This patient complained of spells with a peculiar taste of sudden onset followed by palpitation, flushing of the ears, and a feeling of weakness. Such an attack occurred while he was in my office. His pulse rate was 120 and regular, blood pressure was 180/130 mmHg. Two minutes later the pulse had come down to 92, there were... This content is PDF only. To continue reading please click on the PDF icon. Author, Article, and Disclosure InformationAffiliations: 16 North Goodman Street; Rochester, NY 14607 PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics 1 July 1978Volume 89, Issue 1Page: 149-149KeywordsBlood pressureCatecholaminesEmotionsEpilepsyHeart rateTaste Issue Published: 1 July 1978 PDF DownloadLoading ...
New Test Devised for Cystic Fibrosis
Journal: JAMA (1965)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Dose Escalation Phase 2 Trial of Carfilzomib Combined with Thalidomide and Low-Dose Dexamethason in Newly Diagnosed, Transplant Eligible Patients with Multiple Myeloma. a Trial of the European Myeloma Network
Authors: Pieter Sonneveld, Emilie Asselbergs, Bronno Van der Holt, Sonja Zweegman, Marie jose Kerstens, Edo Vellenga, Marinus van Marwijk-Kooy, Okke de Weerdt, Sarah Lonergan, Antonio Palumbo, Henk Lokhorst
Journal: Blood (2014)
URETERAL IMPLANTATION.
Journal: JAMA (1900)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Pädiatrie und Pädologie, Vienna
Journal: JAMA (1967)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Vincaleukoblastine in Malignant Limphogranuloma
Journal: JAMA (1963)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Paratesticular Paraganglioma
Authors: Vikrant Gosavi, Swati Jadhav, Nalini S. Shah, S. K. Shrivastava, Gagan Prakash, Ravi Shah
Journal: Clinical Nuclear Medicine (2019)

Abstract Paratesticular paragangliomas are a rare occurrence. We present the case of a 43-year-old man who presented with paresthesia and paraparesis and was found to have pathologic fracture involving D1 vertebra as a manifestation of metastasis from a nonsecretory right paratesticular paraganglioma.
Gastrointestinal Pathophysiology
Authors: Howard M. Spiro
Journal: JAMA (1974)

Professor of medicine and physiology at the University of Pennsylvania, Dr. Brooks has put together some material used at his school to teach clinical physiology to medical students. In a sense, the book is mis-titled, as it tries to cover more than "gastrointestinal physiology" and includes material on etiology, symptoms and signs, and even on diagnostic and therapeutic considerations. In this the book may have overextended itself, even though there is always need for continuing refreshment of the clinician's knowledge of physiology and the aberrant trends that lead to disease. After all, a number of other books discuss clinical science and diagnosis. One way to test the book is to see what it tells about several disorders of which the reviewer himself is in need of "brushing up" on. Looking at the section on exudative enteropathy, for example, I did not find the kind of synthesis that the student needs
Role of Schwann Cells in Wallerian Degeneration
Journal: JAMA (1963)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Phase I clinical trial of liposomal-encapsulated doxorubicin citrate and docetaxel, associated with trastuzumab, as neo-adjuvant treatment in stages II and IIIA, HER2-overexpressing breast cancer patients. GEICAM 2003-03 study
Authors: A. Antón, A. Ruiz, M.A. Seguí, L. Calvo, M. Muñoz, J. Lao, F. Sancho, L. Fernández
Journal: Annals of Oncology (2008)
PREDICTED—FOUND
Journal: JAMA (1965)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Vertical transmission of HIV is falling in Britain
Journal: BMJ (1999)

Insulin four times daily is better than twice daily for diabetes in pregnancyDiabetes mellitus complicates about 5% of all pregnan› cies.Good glycaemic control reduces maternal and perinatal morbidity, but there are no data on whether intensifying insulin treatment beyond the conventional twice daily regimen is of benefit.In a randomised con› trolled open label study in nearly 400 diabetic pregnant patients Nachum et al found that a four times daily regimen improved both perinatal outcome and maternal glycaemic control compared with the conventional twice daily regimen (p 1223).The rate of severe maternal hypoglycaemia was, however, similar in both groups.
PREOPERATIVE DYNAMIC CONTRAST-ENHANCED MRI CORRELATES WITH MOLECULAR MARKERS OF HYPOXIA AND VASCULARITY IN SPECIFIC AREAS OF INTRATUMORAL MICROENVIRONMENT AND IS PREDICTIVE OF PATIENT OUTCOME
Authors: R. Jensen, K. Salzman, M. Schabel
Journal: Neuro-Oncology (2014)

BACKGROUND: Measures of tumor vascularity and hypoxia have been correlated with glioma grade and outcome. Dynamic contrast-enhanced MRI (DCE-MRI) can noninvasively map multiple parameters of tumor hypoxia, blood flow, and vascularity. In this prospective observational cohort pilot study, our goal was to use preoperative imaging to correlate specific glioma samples with molecular markers of hypoxia, tumor vascularity, and tumor proliferation along with progression-free and overall patient survival. METHODS: Pharmacokinetic modeling methods were used to generate maps of tumor blood flow (F), extraction fraction (E), permeability-surface area product (PS), transfer constant (Ktrans), washout rate (kep), interstitial volume (v_e), blood volume (vb), capillary transit time (tc), and capillary heterogeneity (α(-1)) from preoperative DCE-MRI data in human glioma patients. Tissue samples were obtained using an MRI-guided intraoperative navigation system from areas of peritumoral edema (PE), active tumor (AT), hypoxic penumbra (HP), and necrotic core (NC). Each sample was evaluated for tumor vascularity, proliferation and expression of hypoxia-regulated molecules including hypoxia inducible factor-1 (HIF-1) and vascular endothelial growth factor (VEGF). Mean DCE-MRI parameter values corresponding to tissue sample sites and marker expression were compared with imaging results. RESULTS: Patient survival correlated with DCE parameters in two cases: α(-1) in AT and ve in areas of PE. Statistically significant correlations between DCE parameters and tissue markers were also observed. Specifically, 1) Vb correlated with VEGF (r = 0.604, p = 0.032) and HIF-1 (r = 0.747, p = 0.043) expression in AT; 2) tc correlated with HIF-1 in AT (r = 0.659, p = 0.017), HP (r = 0.761, p = 0.023), and PE (r = 0.697, p = 0.031) and with VEGF in AT (r = 0.588, p = 0.034) and HP (r = 1.00, p = 0.003); and 3) α(-1) correlated with VEGF in AT (r = 0.599, p = 0.034) and PE (r = 0.973, p < 0.0001). kep correlated with VEGF in PE (r = 0.761, p = 0.0065) and NC (r = 0.931, p = 0.007) and E correlated with HIF-1 expression in NC (r = 0.943, p = 0.017). In addition, MIB-1 index was found to be predictive of OS (p = 0.044) and is correlated with VEGF expression in HP (r = 0.7933, p = 0.0071) and PE (r = 0.4546). Increased microvascular density (MVD) found to correlate with worse patient outcome (p = 0.026). With these results we describe a new clinical trial that we will implement to use these biomarkers in guiding therapeutic interventions for patients with malignant gliomas. CONCLUSIONS: Our findings suggest that it may be possible to use DCE-MRI to make noninvasive preoperative predictions of areas of tumor with increased hypoxia and proliferation. This has the potential to both make unprecedented prognostic decisions and to guide therapies to specific tumor areas SECONDARY CATEGORY: Imaging.
BCL6 Regulates Tonic BCR Signaling in Diffuse Large B-Cell Lymphomas by Repressing the SYK Phosphatase, PTPROt
Authors: Przemyslaw JuszczynsKi, Linfeng Chen, Jose M. Polo, Stella M. Ranuncolo, Riccardo Dalla-Favera, Ari Melnick, Margaret A. Shipp
Journal: Blood (2008)